Genzyme details market potential of Alemtuzumab for MS Wow! Let’s hope it is not too expensive for the NHS. Click here to read the press release! Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like this:Like Loading...